List of SBIR/STTR awards granted to Montana Molecular, Llc
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Montana Molecular, Llc in February, 2021 for $482,109.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DA050357-02 | Phase II | 482,109 | February 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Montana Molecular, Llc in September, 2019 for $221,097.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DA050357-01 | Phase I | 221,097 | September 30, 2019 | |||||||
A SBIR Phase II contract was awarded to Montana Molecular, Llc in July, 2019 for $634,836.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM125390-02 | Phase II | 634,836 | July 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Montana Molecular, Llc in September, 2018 for $250,833.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS108817-01 | Phase I | 250,833 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Montana Molecular, Llc in May, 2022 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI165188-01A1 | Phase II | 300,000 | May 13, 2022 | |||||||
A SBIR Phase I contract was awarded to Montana Molecular, Llc in August, 2017 for $193,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM125390-01 | Phase I | 193,000 | August 21, 2017 | |||||||
A SBIR Phase II contract was awarded to Montana Molecular, Llc in January, 2014 for $1,167,851.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44NS082222-02A1 | Phase II | 1,167,851 | January 15, 2014 | |||||||
A SBIR Phase II contract was awarded to Montana Molecular, Llc in September, 2017 for $437,309.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS082222-04 | Phase II | 437,309 | September 15, 2017 | |||||||
A SBIR Phase II contract was awarded to Montana Molecular, Llc in November, 2014 for $568,652.0 USD from the National Science Foundation. | SBIR | 1430878 | Phase II | 568,652 | November 26, 2014 | |||||||
A SBIR Phase I contract was awarded to Montana Molecular, Llc in January, 2013 for $149,423.0 USD from the National Science Foundation. | SBIR | 1248138 | Phase I | 149,423 | January 1, 2013 | |||||||
A STTR Phase I contract was awarded to Montana Molecular, Llc for $210,092.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41NS056830-01A1 | Phase I | 210,092 | ||||||||
A SBIR Phase I contract was awarded to Montana Molecular, Llc for $348,182.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH096670-01A1 | Phase I | 348,182 | ||||||||
A STTR Phase I contract was awarded to Montana Molecular, Llc for $149,997.0 USD from the National Science Foundation. | STTR | 0711657 | Phase I | 149,997 |
